KIF26B Is Overexpressed in Medulloblastoma and Promotes Malignant Progression by Activating the PI3K/AKT Pathway

被引：6

作者：

Liu, Yajun ^{[1
]}

Zhang, Xi ^{[1
]}

Pan, Ruihan ^{[1
]}

Liang, Xiaolong ^{[1
]}

Liu, Qichang ^{[2
]}

Yang, Chao ^{[1
]}

Li, Xu ^{[1
]}

机构：

[1] Zhejiang Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China

[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China

来源：

ANALYTICAL CELLULAR PATHOLOGY | 2022年 / 2022卷

关键词：

D O I：

10.1155/2022/2552397

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Medulloblastoma is one of the most common malignant tumors of the central nervous system in children. Although KIF2B was reported as an oncogene in several malignant tumor types, its role in medulloblastoma has not been studied so far. The PCR results of our study showed that KIF26B is highly expressed in medulloblastoma, and its high expression is associated with a high clinical stage. Knockdown the expression of KIF26B could significantly impair the proliferation and migration of medulloblastoma cells. KIF26B promotes the malignant progression of medulloblastoma by affecting the expression of phosphorylation of key proteins in the PI3K/AKT signaling pathway. With the help of 740 Y-P, activating the pi3k signaling pathway can partially rescue the phenotype. Therefore, our experimental results suggest that KIF26B is a potential target for medulloblastoma.

引用

页数：9

共 28 条

[1] Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer [J].

Aponte-Lopez, Angelica ;

Fuentes-Panana, Ezequiel M. ;

Cortes-Munoz, Daniel ;

Munoz-Cruz, Samira .

JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018

[2] SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma [J].

Asuthkar, Swapna ;

Venkataraman, Sujatha ;

Avilala, Janardhan ;

Shishido, Katherine ;

Vibhakar, Rajeev ;

Veo, Bethany ;

Purvis, Ian J. ;

Guda, Maheedhara R. ;

Velpula, Kiran K. .

CANCERS, 2022, 14 (07)

[3]

Bleil Cristina Birlem, 2019, Surg Neurol Int, V10, P120, DOI 10.25259/SNI-237-2019

[4] Medulloblastoma: molecular pathways and histopathological classification [J].

Borowska, Anna ;

Jozwiak, Jaroslaw .

ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (03) :659-666

[5] The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K-Akt Pathways [J].

Candido, Saverio ;

Salemi, Rossella ;

Piccinin, Sara ;

Falzone, Luca ;

Libra, Massimo .

PHARMACEUTICS, 2022, 14 (03)

[6] The PTEN-PI3K pathway: of feedbacks and cross-talks [J].

Carracedo, A. ;

Pandolfi, P. P. .

ONCOGENE, 2008, 27 (41) :5527-5541

[7]

Cassia Guilherme de Souza E, 2018, Top Magn Reson Imaging, V27, P479, DOI 10.1097/RMR.0000000000000184

[8] Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome [J].

Cho, Yoon-Jae ;

Tsherniak, Aviad ;

Tamayo, Pablo ;

Santagata, Sandro ;

Ligon, Azra ;

Greulich, Heidi ;

Berhoukim, Rameen ;

Amani, Vladimir ;

Goumnerova, Liliana ;

Eberhart, Charles G. ;

Lau, Ching C. ;

Olson, James M. ;

Gilbertson, Richard J. ;

Gajjar, Amar ;

Delattre, Olivier ;

Kool, Marcel ;

Ligon, Keith ;

Meyerson, Matthew ;

Mesirov, Jill P. ;

Pomeroy, Scott L. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) :1424-1430

[9] Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells [J].

Frasson, Chiara ;

Rampazzo, Elena ;

Accordi, Benedetta ;

Beggio, Giacomo ;

Pistollato, Francesca ;

Basso, Giuseppe ;

Persano, Luca .

BIOMED RESEARCH INTERNATIONAL, 2015, 2015

[10] Recent developments and current concepts in medulloblastoma [J].

Gerber, N. U. ;

Mynarek, M. ;

von Hoff, K. ;

Friedrich, C. ;

Resch, A. ;

Rutkowski, S. .

CANCER TREATMENT REVIEWS, 2014, 40 (03) :356-365

← 1 2 3 →